Eko Murmur Analysis Software (EMAS) vs Tempus ECG-AF
AI Verdict
Choose Eko Murmur Analysis Software (EMAS) if…
Choose Eko Murmur Analysis Software (EMAS) if you require real-time AI-powered analysis of heart sounds during auscultation to detect and differentiate heart murmurs in both adult and pediatric patients. This tool is ideal for clinicians seeking immediate clinical decision support for current heart and lung abnormalities using an integrated digital stethoscope system.
View Eko Murmur Analysis Software (EMAS) →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your objective is to proactively identify patients aged 65 or older who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months. This solution is best suited for integrating into existing cardiology workflows to analyze standard 12-lead ECGs for predictive AF risk assessment.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Murmur Analysis Software (EMAS) | Tempus ECG-AF |
|---|---|---|
| Pricing | Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. | Contact vendor |
| Deployment | Cloud-based, Mobile App | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Murmur Analysis Software (EMAS)Eko Murmur Analysis Software (EMAS) is accessed via a mobile application and integrates with portable digital stethoscopes, offering a direct and intuitive user experience at the point of care. In contrast, Tempus ECG-AF is a software solution integrated into existing healthcare facility systems, implying a more backend, IT-dependent setup without a dedicated user interface for direct clinician interaction.
Clinical Value
TieBoth tools provide significant, FDA-cleared clinical value within their specialized areas. EMAS offers immediate diagnostic support by detecting and differentiating heart murmurs in both adult and pediatric patients. Tempus ECG-AF provides valuable predictive risk assessment for new-onset atrial fibrillation in an at-risk population, enabling proactive intervention.
Pricing & Value
Eko Murmur Analysis Software (EMAS)EMAS offers a transparent, tiered pricing model, including a free basic AI analysis with its mobile app and clear paid subscriptions for advanced features. Tempus ECG-AF requires direct vendor contact for pricing, which lacks transparency, although it does highlight CMS reimbursement availability as a financial benefit for facilities.
Enterprise Readiness
Tempus ECG-AFWhile both tools are HIPAA compliant, have BAAs, and FDA clearance, Tempus ECG-AF is explicitly designed for integration into 'healthcare facility systems' and is compatible with specific enterprise-grade ECG machines from GE and Philips. This suggests a deeper, more robust enterprise integration strategy compared to EMAS's mobile-app-centric deployment with EHR-compatible PDF reports.
Innovation
Tempus ECG-AFTempus ECG-AF's innovation lies in its predictive AI algorithm that analyzes standard 12-lead ECGs to forecast the risk of new-onset AF within 12 months, leveraging a massive training dataset. This represents a more advanced application of AI in proactive disease management. EMAS is also innovative by bringing AI-powered murmur detection and differentiation directly to the point of care via digital stethoscopes, enhancing a fundamental physical examination tool.
Support & Docs
Eko Murmur Analysis Software (EMAS)Eko provides a comprehensive online Help Center with user manuals, FAQs, troubleshooting guides, clinical education, and video tutorials, along with direct contact options and a dedicated enterprise help center. Tempus offers direct technical support via email and phone, but its publicly available self-service documentation for ECG-AF appears less extensive than Eko's structured resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Murmur Analysis Software (EMAS) | Tempus ECG-AF |
|---|---|---|
| Tool Name | Eko Murmur Analysis Software (EMAS) | Tempus ECG-AF |
| Company | Eko Devices | Tempus AI, Inc. |
| Description | FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Primary Function | Detects and differentiates heart murmurs | Identifies risk of developing Atrial Fibrillation/flutter (AF) within 12 months |
| Target Patient Population | Adult and pediatric patients | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
| Data Input | Heart sound (PCG) and optional ECG data from Eko digital stethoscopes | 12-lead ECG recordings from GE Medical Systems and Philips Medical Systems |
Videos
Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and Tempus ECG-AF.